Residual Risk, Unresolved: Lessons of ZEUS and Lp(a)HORIZON Trials

Webinar Overview

Join ACC's Prevention of Cardiovascular Disease Member Section's Leadership Council for an insightful conversation with Steven E. Nissen, MD, MACC, and Paul M. Ridker, MD, MPH, FACC, exploring their late-breaking clinical trials presented at AHA 2026.

Explore the trials' key findings, their implications for clinical practice and practical takeaways for patient care, followed by a live audience Q&A. Visit ACC's meeting coverage page for full coverage of AHA 2026.

Key Objectives/Learning Outcomes: The goal of this webinar is to discuss the ZEUS and Lp(a)HORIZON trials from AHA 2026 including their key findings, implications, and impact on clinical care.

Webinar Participants

Steven E. Nissen, MD, MACC
Paul M. Ridker, MD, MPH, FACC
Eugenia Gianos, MD, FACC
Joseph Ebinger, MD, FACC
Ashley Arana Waring, MD, FACC
Nishant Shah, MD, FACC

Credit Information

No credit is being offered for this webinar.

Clinical Topics: Prevention

Keywords: